Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 455

Similar articles for PubMed (Select 11113727)

2.

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH.

Med Care. 1998 Jul;36(7):1002-12.

PMID:
9674618
3.
4.

Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):421-32. doi: 10.1016/j.ijrobp.2007.12.024. Epub 2008 Mar 5.

PMID:
18325680
5.

Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.

Hedgepeth RC, Labo J, Zhang L, Wood DP Jr.

J Urol. 2009 Jul;182(1):221-7; discussion 227-8. doi: 10.1016/j.juro.2009.02.155. Epub 2009 May 17.

PMID:
19450842
7.

Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.

Rodrigues G, Bauman G, Venkatesan V, Ahmad B, Lock M, Sexton T, D'Souza D, Stitt L, Eid S.

Can J Urol. 2011 Aug;18(4):5802-10.

PMID:
21854712
8.

Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.

Namiki S, Takegami M, Kakehi Y, Suzukamo Y, Fukuhara S, Arai Y.

J Urol. 2007 Aug;178(2):473-7; discussion 477. Epub 2007 Jun 11.

PMID:
17561164
9.

Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.

Guedea F, Ferrer M, Pera J, Aguiló F, Boladeras A, Suárez JF, Cunillera O, Ferrer F, Pardo Y, Martínez E, Ventura M.

Clin Transl Oncol. 2009 Jul;11(7):470-8.

PMID:
19574206
10.

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG.

J Clin Oncol. 2002 Jan 15;20(2):557-66.

PMID:
11786586
11.

Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.

Jo Y, Junichi H, Tomohiro F, Yoshinari I, Masato F.

BJU Int. 2005 Jul;96(1):43-7.

PMID:
15963118
12.

Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index.

Gacci M, Livi L, Paiar F, Detti B, Litwin MS, Bartoletti R, Giubilei G, Cai T, Mariani M, Carini M.

Urology. 2005 Aug;66(2):338-43.

PMID:
16098363
13.

Self-assessed health-related quality of life in men who have completed radiotherapy for prostate cancer: instrument validation and its relation to patient-assessed bother of symptoms.

Wang H, Huang E, Dale W, Campbell T, Ignacio L, Kopnick M, Ray P, Vijayakumar S.

Int J Cancer. 2000 Jun 20;90(3):163-72.

PMID:
10900429
14.

Cross-cultural validation of the UCLA prostate cancer index.

Karakiewicz PI, Kattan MW, Tanguay S, Elhilali MM, Bazinet M, Scardino PT, Aprikian AG.

Urology. 2003 Feb;61(2):302-7.

PMID:
12597935
15.

[Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC].

Ferrer M, Garin O, Pera J, Prats JM, Mendivil J, Alonso J, De Paula B, Herruzo I, Hervas A, Macias V, Mariño A, Ortiz MJ, Pastor S, Ponce De León J, Sancho G; el Grupo Multicéntrico Español de Cáncer de Próstata Localizado.

Med Clin (Barc). 2009 Feb 7;132(4):128-35. doi: 10.1016/j.medcli.2008.01.001. Epub 2009 Feb 4. Spanish.

PMID:
19211071
16.

Measuring patients' expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy.

Symon Z, Daignault S, Symon R, Dunn RL, Sanda MG, Sandler HM.

Urology. 2006 Dec;68(6):1224-9. Epub 2006 Dec 4.

PMID:
17141840
17.

Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer.

Gilbert SM, Dunn RL, Hollenbeck BK, Montie JE, Lee CT, Wood DP, Wei JT.

J Urol. 2010 May;183(5):1764-9. doi: 10.1016/j.juro.2010.01.013. Epub 2010 Mar 17.

PMID:
20299056
18.

Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.

Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M.

Jpn J Clin Oncol. 2009 Aug;39(8):502-8. doi: 10.1093/jjco/hyp053. Epub 2009 May 28.

19.
20.

Responsiveness of the University of California-Los Angeles Prostate Cancer Index.

Bergman J, Saigal CS, Kwan L, Litwin MS.

Urology. 2010 Jun;75(6):1418-23. doi: 10.1016/j.urology.2009.04.070. Epub 2009 Jul 8.

PMID:
19589573
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk